Developments in Nonsteroidal Antiandrogens Targeting the Androgen Receptor

Enemy of the (pro)state! The androgen receptor (AR) is closely involved in the formation and growth of prostate cancer. Currently, targeting the AR is a hot research area in the design and development of drugs against prostate cancer. Herein, nonsteroidal antiandrogen agents that target the AR are reviewed.